References
- Diener HC, Montagna P, Gács G et al. Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia26(5), 537–547 (2006).
- Lipton RB, Stewart WF, Stone AM, Láinez MJ, Sawyer JP. Disability in strategies of care study group. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) study: a randomized trial. JAMA284(20), 2599–2605 (2000).
- Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache47(10), 1443–1446 (2007).
- Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin. Ther.26(2), 214–223 (2004).
- Tepper SJ, Kori SH, Borland SW et al. Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia. Headache52(1), 37–47 (2012).
- Lipton RB, Dodick DW, Silberstein SD et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol.9(4), 373–380 (2010).
- Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache49(7), 983–989 (2009).
- Rapoport AM, Tepper SJ, Bigal Marcelo E, Sheftell FD. The triptan formulations: how to match patients and products. CNS Drugs17(6), 431–447 (2003).